Reprocessed Medical Devices Market Size, Share & Trends Analysis Report By Product (Cardiovascular, Laparoscopic), By Type (Third-party, In-house), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Reprocessed Medical Devices Market Growth & Trends

The global reprocessed medical devices market size is estimated to reach USD 5.08 billion by 2030, registering to grow at a CAGR of 16.95% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing need for affordable & effective medical devices and growing concern regarding the rising amounts of medical waste generated by healthcare facilities are expected to drive the market. In addition, the long-term cost-efficiency associated with these devices as compared to that of the original device is expected to further drive the market growth. Medical device reprocessing has become an increasingly popular way of saving costs among healthcare organizations. According to the Association of Medical Device Reprocessors (AMDR), these reprocessed devices are typically 30-50% cheaper than new ones. Hospitals and other healthcare facilities take advantage of this cost-effective resource to enhance services and advance their technology.

It also allows them to allocate funds to important areas like hiring additional personnel or updating equipment, while still ensuring quality of care. Moreover, data published by the AMDR reveals that hospitals are responsible for 8.5% of the Greenhouse Gas (GHG) emissions in the U.S. and 5% of global outputs. Studies suggest these emissions reduce life expectancy in the U.S. by 388,000 disability-adjusted years. Over 80% of emissions come from the healthcare supply chain. A 2021 study conducted by the Fraunhofer Institute for Environmental, Safety, and Energy Technology concluded that using reprocessed medical equipment could drastically reduce the global warming impact of such devices by 40%, reduce ozone depletion by 90%, and diminish the utilization of the finite abiotic resources by 29%. The COVID-19 pandemic had a significant impact on the market. However, an increasing amount of medical waste around the world has become a major concern.

Reprocessing can help address this challenge by reducing waste and prolonging the life of products. Medical device reprocessors have begun introducing sustainable solutions to improve waste management and prevent health risks to the public, patients, healthcare staff, and waste workers. All such factors are expected to drive the industry growth during the forecast period. Several medical device companies, including subsidiaries of prominent organizations, such as Arjo, Cardinal, Medline, and Stryker, engage in remanufacturing Single-Use Devices (SUDs) as part of their sustainability initiatives. For instance, in January 2023, Vanguard AG announced its strategic partnership with Leeds Teaching Hospitals NHS Trust, one of the UK’s largest and most prominent healthcare providers. This collaboration aims to promote the use of remanufactured medical devices to reduce costs and foster a more sustainable healthcare environment.

Reprocessed Medical Devices Market Report Highlights

  • The cardiovascular segment dominated the market in 2024 with the largest revenue share of 56.62% and is also anticipated to register the fastest CAGR of 17.20% over the forecast period.
  • The third-party reprocessing segment dominated the market in 2024 with the largest revenue share of 66.47%.
  • The hospitals segment dominated the market in 2024 with the largest revenue share of 42.57%.
  • The North America reprocessed medical devices industry dominated globally in 2024 with the largest revenue share of 46.11%.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Reprocessed Medical Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing need to reduce medical waste in healthcare settings
3.2.1.2. Rising awareness about the advantages of reprocessed devices
3.2.1.3. Increasing level of supply chain cost savings in healthcare facilities
3.2.2. Market restraint analysis
3.2.2.1. Possibility of material change and cross-contamination with reprocessed equipment
3.2.2.2. Prejudice regarding the quality of reprocessed medical devices
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Reprocessed Medical Devices Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1. Reprocessed Medical Devices Market: Product Movement Analysis and Market Share
4.2. Reprocessed Medical Devices Market: Segment Dashboard
4.3. Cardiovascular Devices
4.3.1. Cardiovascular devices market, 2018 - 2030 (USD Million)
4.3.2. Blood Pressure Cuffs
4.3.2.1. Blood Pressure Cuffs market, 2018 - 2030 (USD Million)
4.3.3. Positioning Devices
4.3. Positioning Devices market, 2018 - 2030 (USD Million)
4.3.4. Cardiac Stabilization Devices
4.3.4.1. Cardiac Stabilization Devices market, 2018 - 2030 (USD Million)
4.3.5. Diagnostic Electrophysiology Catheters
4.3.5.1. Diagnostic Electrophysiology Catheters market, 2018 - 2030 (USD Million)
4.3.6. Deep Vein Thrombosis Compression Sleeves
4.3.6.1. Deep Vein Thrombosis Compression Sleeves market, 2018 - 2030 (USD Million)
4.3.7. Electrophysiology Cables
4.3.7.1. Electrophysiology Cables market, 2018 - 2030 (USD Million)
4.4. Laparoscopic Devices
4.4.1. Laparoscopic devices market, 2018 - 2030 (USD Million)
4.4.2. Harmonic Scalpels
4.4.2.1. Harmonic Scalpels market, 2018 - 2030 (USD Million)
4.4.3. Endoscopic Trocars
4.4.3.1. Endoscopic Trocars market, 2018 - 2030 (USD Million)
4.5. Gastroenterology Devices
4.5.1. Gastroenterology devices market, 2018 - 2030 (USD Million)
4.5.2. Biopsy Forceps
4.5.2.1. Biopsy Forceps market, 2018 - 2030 (USD Million)
4.5.3. Others
4.5.3.1. Others market, 2018 - 2030 (USD Million)
4.6. General Surgery Devices
4.6.1. General surgery devices, market, 2018 - 2030 (USD Million)
4.6.2. Pressure Bags
4.6.2.1. Pressure Bags market, 2018 - 2030 (USD Million)
4.6.3. Balloon Inflation Devices
4.6.3.1. Balloon Inflation Devices market, 2018 - 2030 (USD Million)
4.7. Orthopedic Devices
4.7.1. Orthopedic devices market, 2018 - 2030 (USD Million)
Chapter 5. Reprocessed Medical Devices Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
5.1. Reprocessed Medical Devices Market: Type Movement Analysis and Market Share
5.2. Reprocessed Medical Devices Market: Type Segment Dashboard
5.3. Third-Party Reprocessing
5.3.1. Third-party reprocessing market, 2018 - 2030 (USD Million)
5.4. In-House Reprocessing
5.4.1. In-house reprocessing market, 2018 - 2030 (USD Million)
Chapter 6. Reprocessed Medical Devices Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1. Reprocessed Medical Devices Market: End-Use Movement Analysis and Market Share
6.2. Reprocessed Medical Devices Market: End-Use Segment Dashboard
6.3. Hospitals
6.3.1. Hospitals market, 2018 - 2030 (USD Million)
6.4. Home Healthcare
6.4.1. Home healthcare market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others market, 2018 - 2030 (USD Million)
Chapter 7. Region, By Product, By End Use, 2018- 2030 (USD Million)
7.1. Regional Market Dashboard
7.2. Regional marketplace: Key takeaways
7.3. North America
7.3.1. North America reprocessed medical devices market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework and reimbursement scenario
7.3.2.3. Competitive scenario
7.3.2.4. U.S. reprocessed medical devices market, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework and reimbursement scenario
7.3.3.3. Competitive scenario
7.3.3.4. Canada reprocessed medical devices market, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Regulatory framework and reimbursement scenario
7.3.4.3. Competitive scenario
7.3.4.4. Mexico reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework and reimbursement scenario
7.4.2.3. Competitive scenario
7.4.2.4. UK reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework and reimbursement scenario
7.4.3.3. Competitive scenario
7.4.3.4. Germany reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework and reimbursement scenario
7.4.4.3. Competitive scenario
7.4.4.4. France reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework and reimbursement scenario
7.4.5.3. Competitive scenario
7.4.5.4. Italy reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework and reimbursement scenario
7.4.6.3. Competitive scenario
7.4.6.4. Spain reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.7. Norway
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework and reimbursement scenario
7.4.7.3. Competitive scenario
7.4.7.4. Norway reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework and reimbursement scenario
7.4.8.3. Competitive scenario
7.4.8.4. Sweden reprocessed medical devices market, 2018 - 2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework and reimbursement scenario
7.4.9.3. Competitive scenario
7.4.9.4. Denmark reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework and reimbursement scenario
7.5.1.3. Competitive scenario
7.5.1.4. Japan reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework and reimbursement scenario
7.5.2.3. Competitive scenario
7.5.2.4. China reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework and reimbursement scenario
7.5.3.3. Competitive scenario
7.5.3.4. India reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework and reimbursement scenario
7.5.4.3. Competitive scenario
7.5.4.4. Australia reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework and reimbursement scenario
7.5.5.3. Competitive scenario
7.5.5.4. South Korea reprocessed medical devices market, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework and reimbursement scenario
7.5.6.3. Competitive scenario
7.5.6.4. Thailand reprocessed medical devices market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework and reimbursement scenario
7.6.1.3. Competitive scenario
7.6.1.4. Brazil reprocessed medical devices market, 2018 - 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework and reimbursement scenario
7.6.2.3. Competitive scenario
7.6.2.4. Argentina reprocessed medical devices market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework and reimbursement scenario
7.7.1.3. Competitive scenario
7.7.1.4. South Africa reprocessed medical devices market, 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework and reimbursement scenario
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia reprocessed medical devices market, 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework and reimbursement scenario
7.7.3.3. Competitive scenario
7.7.3.4. UAE reprocessed medical devices market, 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework and reimbursement scenario
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait reprocessed medical devices market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Stryker
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Innovative Health
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. NEScientific, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Medline Industries, LP.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Arjo
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cardinal Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. SureTek Medical
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Soma Tech Intl
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Johnson & Johnson MedTech
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. GE Healthcare
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings